The straight segment (S3) of the proximal tubule is predominantly damaged during renal ischemia-reflow, whereas medullary thick ascending limbs (mTALs) are principally affected in other models of hypoxic acute tubular necrosis (ATN). Since the latter injury pattern largely depends on the extent of reabsorptive activity during hypoxic stress, we hypothesized that proximal tubular damage might attenuate downstream mTAL injury by means of diminished distal solute delivery for reabsorption. In isolated rat kidneys perfused for 90 min with oxygenated Krebs-Henseleit solution, mTAL necrosis developed in 75 ± 3% of tubules in the mid-inner stripe of the outer medulla. By contrast, S3 segments in the outer stripe were minimally affected, with tubular fragmentation involving some 5 ± 2% of tubules. In kidneys subjected in vivo to proximal tubular injury and subsequently used for isolated perfusion studies, the injury pattern was inverted: following 20 and 30 min ischemia and reflow for 24 h, S3 fragmentation rose to 18 ± 16% and 72 ± 13%, while mTAL damage was reduced to 33 ± 10 and 24 ± 8%, respectively. In kidneys subjected in vivo to D-serine S3 necrosis rose to 100%, while mTAL damage fell to 1 ± 1% (p < 0.001). Substantial S3 tubular collapse (involving approximately 30% of tubules) and inner stripe interstitial hemorrhage were also noted, exclusively in kidneys subjected to ischemia-reflow. Proximal tubular necrosis alone or in combination with collapse inversely correlated with mTAL necrosis (R = –0.51 and –0.72, respectively, p < 0.003). This cogent inverse association might imply that disruption of the proximal nephron attenuates downstream mTAL necrosis by a reduction of distal tubular reabsorptive workload.

1.
Lieberthal W, Nigam SK: Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 1998;275:F623–F631.
2.
Lieberthal W, Nigam SK: Acute renal failure. II. Experimental models of acute renal failure; imperfect but indispensable. Am J Physiol 2000;278:F1–F12.
3.
Glaubermann B, Trump BF: Studies on the pathogenesis of ischemic cell injury. III. Morphological changes of the proximal pars recta tubule (P3) of the rat kidney made ischemic in vivo. Virchows Arch [B] 1975;19:303–323.
4.
Brezis M, Rosen S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 1995;332:647–655.
5.
N Heyman SN, Fuchs S, Brezis M: The role of medullary ischemia in acute renal failure. New Horizons 1995;3:597–607.
6.
Jaffe R, Ariel I, Beeri R, Paltiel O, Hiss Y, Rosen S, Brezis M: Frequent apoptosis in human kidneys after acute renal hypoperfusion. Exp Nephrol 1997;5:399–403.
7.
Beeri R, Symon Z, Brezis M, Ben Sasson SA, Baehr PH, Rosen S, Zager RA: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47:1806–1810.
8.
Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991;40:632–642.
9.
Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygen balance: Studies in isolated in intact rat kidneys. J Clin Invest 1991;88:390–395.
10.
Heyman SN, Brezis M, Reubinoff CA, Greenfeld Z, Lechene C, Epstein F, Rosen S: Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401–412.
11.
Epstein FH, Silva P, Spokes K, Brezis M, Rosen S: Renal medullary ATPase activity and hypoxic injury in perfused rat kidneys. Kidney Int 1989;36:768–772.
12.
Heyman SN, Brezis M, Epstein FH, Spokes K, Rosen S: Effect of glycine and hypertrophy on renal outer medullary hypoxic injury in ischemia reflow and contrast nephropathy. Am J Kid Dis 1992;19:578–586.
13.
Brezis M, Agmon Y, Epstein FH: Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 1994;267:F1059–F1062.
14.
Liss P, Nygren A, Ulfendahl HR, Erikson U: Effect of furosemide or mannitol before injection of a non-ionic contrast medium on intrarenal oxygen tension. Adv Exp Med Biol 1999;471:353–359.
15.
Brezis M, Rosen S, Silva P, Epstein FH: Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 1984;25:65–72.
16.
Heyman SN, Rosen S, Epstein FH, Spokes K, Brezis M: Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int 1994;45:981–985.
17.
Heyman SN, Brezis M, Greenfeld Z, Rosen S: Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 1989;14:377–385.
18.
Epstein FH, Prasad P: Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 2000;57:2080–2083.
19.
Brezis M, Heyman SN, Epstein FH: Determinants of intrarenal oxygenation. 2. Hemodynamic effects. Am J Physiol 1994;267:F1063–F1068.
20.
Liss P, Nygren A, Revsbech NP, Ulfendahl HR: Intrarenal oxygen tension measured by a modified clark electrode at normal and low blood pressure and after the injection of x-ray contrast media. Pflügers Arch 1997;434:705–711.
21.
Kribben A, Edelstein CL, Schrier RW: Pathophysiology of acute renal failure. J Nephrol 1999;12(suppl 2):S142–S151.
22.
Ross BD, Epstein FH, Leaf A: Sodium reabsorption in the perfused rat kidney. Am J Physiol 1973;225:1165–1171.
23.
Carone FA, Nakamura S, Goldman B: Urinary loss of phosphate, and protein by diffusion into proximal straight tubules injured by D-serine and maleic acid. Lab Invest 1985;52:605–610.
24.
Brezis M, Rosen S, Silva P, Epstein FH: Selective vulnerability of the medullary thick ascending limb to anoxia in isolated perfused rat kidney. J Clin Invest 1984;73:182–190.
25.
Brezis M, Shanley P, Silva P, Spokes K, Lear S, Epstein FH, Rosen S: Disparate mechanisms for hypoxic cell injury in different nephron segments: Studies in the isolated perfused rat kidney. J Clin Invest 1985;76:1796–1806.
26.
Shanley PF, Rosen MD, Brezis M, Silva P, Epstein FH, Rosen S: Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney. Am J Pathol 1986;122:462–468.
27.
Vogt BA, Alam J, Croatt AJ, Vercellotti GM, Nath KA: Acquired resistance of acute oxidative stress: Possible role of heme oxygenase and ferritin. Lab Invest 1995;72:474–483.
28.
Backenorth R, Schuger L, Wald H, Popovtzer MM: Glycerol-induced acute renal failure attenuates subsequent HgCl2-associated nephrotoxicity: Correlation of renal function and morphology. Ren Fail 1998;20:15–26.
29.
Vogt BA, Shanley TP, Croatt A, Alam J, Johnson KJ, Nath KA: Glomerular inflammation induces resistance to tubular injury in the rat: A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest 1996;98:2139–2145.
30.
Zager RA, Iwata M, Burkhart KM, Schimpf BA: Post-ischemic acute renal failure protects proximal tubules from O2 deprivation injury, possibly by inducing uremia. Kidney Int 1994;45:1760–1768.
31.
Zager RA: Heme protein-induced tubular cytoresistance: Expression at the plasma membrane level. Kidney Int 1995;47:1336–1345.
32.
Zager RA, Baltes LA: Progressive renal insufficiency induces increasing protection against ischemic acute renal failure. J Lab Clin Med 1984;103:511–523.
33.
Jia L, Bonaventura JL, Bonaventura J, Stamler JS: S-nitrosohemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996;380:221–226.
34.
Hogg N, Griffith OW: The biological chemistry of NO; in Goligorsky MS, Gross SS (eds): Nitric Oxide and the Kidney. New York, Chapman & Hall, 1997, pp 3–21.
35.
Dinour D, Agmon Y, Brezis M: Adenosine: An emerging role in the control of renal medullary oxygenation? Exp Nephrol 1993;1:152–157.
36.
Heyman SN, Rosen S, Fuchs S, Epstein FH, Brezis M: Myoglobinuric acute renal failure in the rat: A role for medullary hypoperfusion, hypoxia and tubular obstruction. J Am Soc Nephrol 1996;7:1066–1074.
37.
Holt S, Moore K: Pathogenesis of renal failure in rhabdomyolysis: The role of myoglobin. Exp Nephrol 2000;8:72–76.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.